1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Anal Fistula Treatment Market
4. Market Overview
    4.1. Introduction
        4.1.1. Product Definition
        4.1.2. Industry Evolution/Developments
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Anal Fistula Treatment Market Analysis and Forecast, 2017–2031
5. Key Insights
    5.1. Pipeline Analysis
    5.2. Key Product/Brand Analysis
    5.3. Key Mergers & Acquisitions
    5.4. COVID-19 Pandemic Impact on Industry
6. Global Anal Fistula Treatment Market Analysis and Forecast, by Treatment Type
    6.1. Introduction & Definition
    6.2. Key Findings/Developments
    6.3. Market Value Forecast, by Treatment Type, 2017–2031
        6.3.1. Non-surgical
            6.3.1.1. Drugs
            6.3.1.2. Others (fibrin glue, adipose stem cell therapy, etc.)
        6.3.2. Surgical
            6.3.2.1. Fistulotomy
            6.3.2.2. Bioprosthetic Plus
            6.3.2.3. Advancement Flap Procedures
            6.3.2.4. Seton Techniques
            6.3.2.5. Others
    6.4. Market Attractiveness Analysis, by Treatment Type
7. Global Anal Fistula Treatment Market Analysis and Forecast, by Application
    7.1. Introduction & Definition
    7.2. Key Findings/Developments
    7.3. Market Value Forecast, by Application, 2017–2031
        7.3.1. Intersphincteric
        7.3.2. Transsphincteric
        7.3.3. Suprasphincteric
        7.3.4. Extrasphincteric
        7.3.5. Others
    7.4. Market Attractiveness Analysis, by Application
8. Global Anal Fistula Treatment Market Analysis and Forecast, by End-user
    8.1. Introduction & Definition
    8.2. Key Findings/Developments
    8.3. Market Value Forecast, by End-user, 2017–2031
        8.3.1. Hospitals & Ambulatory Surgical Centers
        8.3.2. Clinics
        8.3.3. Others
    8.4. Market Attractiveness Analysis, by End-user
9. Global Anal Fistula Treatment Market Analysis and Forecast, by Region
    9.1. Key Findings
    9.2. Market Value Forecast, by Region, 2017–2031
        9.2.1. North America
        9.2.2. Europe
        9.2.3. Asia Pacific
        9.2.4. Latin America
        9.2.5. Middle East & Africa
    9.3. Market Attractiveness Analysis, by Region
10. North America Anal Fistula Treatment Market Analysis and Forecast
    10.1. Introduction
    10.2. Key Findings
    10.3. Market Value Forecast, by Treatment Type, 2017–2031
        10.3.1. Non-surgical
            10.3.1.1. Drugs
            10.3.1.2. Others (fibrin glue, adipose stem cell therapy, etc.)
        10.3.2. Surgical
            10.3.2.1. Fistulotomy
            10.3.2.2. Bioprosthetic Plus
            10.3.2.3. Advancement Flap Procedures
            10.3.2.4. Seton Techniques
            10.3.2.5. Others
    10.4. Market Value Forecast, by Application, 2017–2031
        10.4.1. Intersphincteric
        10.4.2. Transsphincteric
        10.4.3. Suprasphincteric
        10.4.4. Extrasphincteric
        10.4.5. Others
    10.5. Market Value Forecast, by End-user, 2017–2031
        10.5.1. Hospitals & Ambulatory Surgical Centers
        10.5.2. Clinics
        10.5.3. Others
    10.6. Market Value Forecast, by Country, 2017–2031
        10.6.1. U.S.
        10.6.2. Canada
    10.7. Market Attractiveness Analysis
        10.7.1. By Treatment Type
        10.7.2. By Application
        10.7.3. By End-user
        10.7.4. By Country
11. Europe Anal Fistula Treatment Market Analysis and Forecast
    11.1. Introduction
    11.2. Key Findings
    11.3. Market Value Forecast, by Treatment Type, 2017–2031
        11.3.1. Non-surgical
            11.3.1.1. Drugs
            11.3.1.2. Others (fibrin glue, adipose stem cell therapy, etc.)
        11.3.2. Surgical
            11.3.2.1. Fistulotomy
            11.3.2.2. Bioprosthetic Plus
            11.3.2.3. Advancement Flap Procedures
            11.3.2.4. Seton Techniques
            11.3.2.5. Others
    11.4. Market Value Forecast, by Application, 2017–2031
        11.4.1. Intersphincteric
        11.4.2. Transsphincteric
        11.4.3. Suprasphincteric
        11.4.4. Extrasphincteric
        11.4.5. Others
    11.5. Market Value Forecast, by End-user, 2017–2031
        11.5.1. Hospitals & Ambulatory Surgical Centers
        11.5.2. Clinics
        11.5.3. Others
    11.6. Market Value Forecast, by Country/Sub-region, 2017–2031
        11.6.1. Germany
        11.6.2. U.K.
        11.6.3. France
        11.6.4. Italy
        11.6.5. Spain
        11.6.6. Rest of Europe
    11.7. Market Attractiveness Analysis
        11.7.1. By Treatment Type
        11.7.2. By Application
        11.7.3. By End-user
        11.7.4. By Country/Sub-region
12. Asia Pacific Anal Fistula Treatment Market Analysis and Forecast
    12.1. Introduction
    12.2. Key Findings
    12.3. Market Value Forecast, by Treatment Type, 2017–2031
        12.3.1. Non-surgical
            12.3.1.1. Drugs
            12.3.1.2. Others (fibrin glue, adipose stem cell therapy, etc.)
        12.3.2. Surgical
            12.3.2.1. Fistulotomy
            12.3.2.2. Bioprosthetic Plus
            12.3.2.3. Advancement Flap Procedures
            12.3.2.4. Seton Techniques
            12.3.2.5. Others
    12.4. Market Value Forecast, by Application, 2017–2031
        12.4.1. Intersphincteric
        12.4.2. Transsphincteric
        12.4.3. Suprasphincteric
        12.4.4. Extrasphincteric
        12.4.5. Others
    12.5. Market Value Forecast, by End-user, 2017–2031
        12.5.1. Hospitals & Ambulatory Surgical Centers
        12.5.2. Clinics
        12.5.3. Others
    12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
        12.6.1. China
        12.6.2. Japan
        12.6.3. India
        12.6.4. Australia & New Zealand
        12.6.5. Rest of Asia Pacific
    12.7. Market Attractiveness Analysis
        12.7.1. By Treatment Type
        12.7.2. By Application
        12.7.3. By End-user
        12.7.4. By Country/Sub-region
13. Latin America Anal Fistula Treatment Market Analysis and Forecast
    13.1. Introduction
    13.2. Key Findings
    13.3. Market Value Forecast, by Treatment Type, 2017–2031
        13.3.1. Non-surgical
            13.3.1.1. Drugs
            13.3.1.2. Others (fibrin glue, adipose stem cell therapy, etc.)
        13.3.2. Surgical
            13.3.2.1. Fistulotomy
            13.3.2.2. Bioprosthetic Plus
            13.3.2.3. Advancement Flap Procedures
            13.3.2.4. Seton Techniques
            13.3.2.5. Others
    13.4. Market Value Forecast, by Application, 2017–2031
        13.4.1. Intersphincteric
        13.4.2. Transsphincteric
        13.4.3. Suprasphincteric
        13.4.4. Extrasphincteric
        13.4.5. Others
    13.5. Market Value Forecast, by End-user, 2017–2031
        13.5.1. Hospitals & Ambulatory Surgical Centers
        13.5.2. Clinics
        13.5.3. Others
    13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
        13.6.1. Brazil
        13.6.2. Mexico
        13.6.3. Rest of Latin America
    13.7. Market Attractiveness Analysis
        13.7.1. By Treatment Type
        13.7.2. By Application
        13.7.3. By End-user
        13.7.4. By Country/Sub-region
14. Middle East & Africa Anal Fistula Treatment Market Analysis and Forecast
    14.1. Introduction
    14.2. Key Findings
    14.3. Market Value Forecast, by Treatment Type, 2017–2031
        14.3.1. Non-surgical
            14.3.1.1. Drugs
            14.3.1.2. Others (fibrin glue, adipose stem cell therapy, etc.)
        14.3.2. Surgical
            14.3.2.1. Fistulotomy
            14.3.2.2. Bioprosthetic Plus
            14.3.2.3. Advancement Flap Procedures
            14.3.2.4. Seton Techniques
            14.3.2.5. Others
    14.4. Market Value Forecast, by Application, 2017–2031
        14.4.1. Intersphincteric
        14.4.2. Transsphincteric
        14.4.3. Suprasphincteric
        14.4.4. Extrasphincteric
        14.4.5. Others
    14.5. Market Value Forecast, by End-user, 2017–2031
        14.5.1. Hospitals & Ambulatory Surgical Centers
        14.5.2. Clinics
        14.5.3. Others
    14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
        14.6.1. GCC Countries
        14.6.2. South Africa
        14.6.3. Rest of Middle East & Africa
    14.7. Market Attractiveness Analysis
        14.7.1. By Treatment Type
        14.7.2. By Application
        14.7.3. By End-user
        14.7.4. By Country/Sub-region
15. Competition Landscape
    15.1. Market Player – Competitive Matrix (by Tier and Size of Companies)
    15.2. Market Share Analysis, by Company (2022)
    15.3. Company Profiles
        15.3.1. Becton, Dickinson and Company
            15.3.1.1. Company Overview
            15.3.1.2. Product Portfolio
            15.3.1.3. SWOT Analysis
            15.3.1.4. Financial Overview
            15.3.1.5. Strategic Overview
        15.3.2. Biolitec AG
            15.3.2.1. Company Overview
            15.3.2.2. Product Portfolio
            15.3.2.3. SWOT Analysis
            15.3.2.4. Financial Overview
            15.3.2.5. Strategic Overview
        15.3.3. Cook Medical
            15.3.3.1. Company Overview
            15.3.3.2. Product Portfolio
            15.3.3.3. SWOT Analysis
            15.3.3.4. Financial Overview
            15.3.3.5. Strategic Overview
        15.3.4. Gem srl
            15.3.4.1. Company Overview
            15.3.4.2. Product Portfolio
            15.3.4.3. SWOT Analysis
            15.3.4.4. Financial Overview
            15.3.4.5. Strategic Overview
        15.3.5. KARL STORZ SE & Co. KG
            15.3.5.1. Company Overview
            15.3.5.2. Product Portfolio
            15.3.5.3. SWOT Analysis
            15.3.5.4. Financial Overview
            15.3.5.5. Strategic Overview
        15.3.6. Medtronic plc
            15.3.6.1. Company Overview
            15.3.6.2. Product Portfolio
            15.3.6.3. SWOT Analysis
            15.3.6.4. Financial Overview
            15.3.6.5. Strategic Overview
        15.3.7. TiGenix NV
            15.3.7.1. Company Overview
            15.3.7.2. Product Portfolio
            15.3.7.3. SWOT Analysis
            15.3.7.4. Financial Overview
            15.3.7.5. Strategic Overview
        15.3.8. W.L. Gore & Associates, Inc. (Gore Medical)
            15.3.8.1. Company Overview
            15.3.8.2. Product Portfolio
            15.3.8.3. SWOT Analysis
            15.3.8.4. Financial Overview
            15.3.8.5. Strategic Overview
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


 
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			